Building a pipeline of immuno-infectiology candidates to fight against anti-microbial resistance
Alpioner Therapeutics is a biotech company developing a whole-cell vaccine platform consisting of genetically optimized strains of human pathogens undergoing an attenuation process which delivers a Killed but Metabolically Active (KBMA) vaccine substance. This platform has already generated a first candidate targeting a human multi-resistant pathogen, Pseudomonas aeruginosa. It carries on the potential for further applications against other resistant pathogens.
Alpioner Therapeutics mission is to build a pipeline of immuno-infectiology candidates to fight against anti-microbial resistance (AMR).
Alpioner Therapeutics is a biotechnology company developing the first KBMA vaccine candidate against pseudomonas aeruginosa
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() MEDICALPS Business Consulting and Services | MEDICALPS Business Consulting and Services | Other 16 Apr 2024 | | |
![]() SATT Ouest Valorisation Research, Startup accelerator & VC, Research Services | SATT Ouest Valorisation Research, Startup accelerator & VC, Research Services | Other 29 Feb 2024 | | |
![]() Erganeo Research, National and local authorities, Research Services | Erganeo Research, National and local authorities, Research Services | Other 29 Feb 2024 | | |
![]() SATT Sud-Est Research, National and local authorities, Research Services | SATT Sud-Est Research, National and local authorities, Research Services | Other 29 Feb 2024 | | |
![]() SAYENS Research, Startup accelerator & VC, Research Services | SAYENS Research, Startup accelerator & VC, Research Services | Other 29 Feb 2024 | | |
![]() SATT Paris-Saclay Research, Startup accelerator & VC, Research Services | SATT Paris-Saclay Research, Startup accelerator & VC, Research Services | Other 29 Feb 2024 | | |
![]() Maddyness Media, Media Production | Maddyness Media, Media Production | Other 30 Jun 2024 | | |
![]() | Invest In Grenoble Alpes | Other 2 Jul 2024 | |